Belite Bio

(NASDAQ) BLTE

Current Price$135.36

Market Cap$5.89B

Since IPO (2022)+1,288%

5 YearN/A

1 Year+108%

1 Month-13%

Belite Bio Financials at a Glance

Market Cap

$5.89B

Revenue (TTM)

$0.00

Net Income (TTM)

-$90.27M

EPS (TTM)

-$2.53

P/E Ratio

-58.13

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$135.36

Volume

19,278

Open

$143.31

Price

$135.36

Volume

19,278

Open

$143.31

Previous Close

$135.36

Daily Range

$130.23 - $143.31

52-Week Range

$56.10 - $200.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$135.36

Volume

19,278

Open

$143.31

Previous Close

$135.36

Daily Range

$130.23 - $143.31

52-Week Range

$56.10 - $200.00

BLTE News

Person in a lab gazing into a microscope

BLTE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Belite Bio

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Yue Hsin Lin, MD, PhD

Website

www.belitebio.com

Headquarters

San Diego, CA 92121, US

BLTE Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-19%

Return on Capital

-13%

Return on Assets

-12%

Earnings Yield

-1.72%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.89B

Shares Outstanding

40.09M

Volume

19.28K

Avg. Volume

168.75K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$84.21M

EBITDA

-$84.21M

Operating Cash Flow

-$36.99M

Capital Expenditure

-$178.00K

Free Cash Flow

-$37.17M

Cash & ST Invst.

$492.42M

Total Debt

$429.00K

Belite Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$5.89B

N/A

Market Cap/Employee

$235.70M

N/A

Employees

N/A

Net Income

-$26.94M

-88.7%

EBITDA

-$32.68M

-111.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$491.99M

+240.2%

Accounts Receivable

$718.00K

+20.9%

Inventory

$0.00

N/A

Long Term Debt

$188.00K

-28.0%

Short Term Debt

$241.00K

-12.7%

Return on Assets

-11.57%

N/A

Return on Invested Capital

-13.15%

N/A

Free Cash Flow

-$10.56M

N/A

Operating Cash Flow

-$10.39M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PRAXPraxis Precision Medicines, Inc.

PRAXPraxis Precision Medicines, Inc.$258.08-23.00%

LGNDLigand Pharmaceuticals Incorporated

LGNDLigand Pharmaceuticals Incorporated$232.76+1.30%

MIRMMirum Pharmaceuticals, Inc.

MIRMMirum Pharmaceuticals, Inc.$92.17-4.32%

ACADACADIA Pharmaceuticals Inc.

ACADACADIA Pharmaceuticals Inc.$20.89-2.93%

CRNXCrinetics Pharmaceuticals, Inc.

CRNXCrinetics Pharmaceuticals, Inc.$32.61-5.53%

VKTXViking Therapeutics, Inc.

VKTXViking Therapeutics, Inc.$29.29-6.33%

DYNDyne Therapeutics, Inc.

DYNDyne Therapeutics, Inc.$17.24-7.46%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

HPEHewlett Packard Enterprise

HPEHewlett Packard Enterprise$56.15+0.19%

NOKNokia

NOKNokia$16.85+0.04%

INTCIntel

INTCIntel$107.93-0.01%

ONDSOndas

ONDSOndas$13.58+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$17.74-0.05%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$38.05-0.06%

FFord Motor Company

FFord Motor Company$16.15-0.03%

Questions About BLTE

What is the current price of Belite Bio?

Belite Bio is trading at $135.36 per share.

What is the 52-week range for Belite Bio?

Over the past 52 weeks, Belite Bio has traded between $56.10 and $200.00.

How much debt does Belite Bio have?

As of the most recent reporting period, Belite Bio reported total debt of $429.00K.

How much cash does Belite Bio have on hand?

Belite Bio reported $276.40M in cash and cash equivalents in its most recent financial results.

What is Belite Bio’s dividend yield?

Belite Bio does not currently have a dividend yield.

Belite Bio

Belite Bio Financials at a Glance

BLTE News

Why Belite Bio Stock Soared on Monday

Why Shares of Belite Bio Soared This Week

Why Shares of Belite Bio Are Slumping Wednesday

3 Breakout Growth Stocks to Buy for the Long Haul

2 Stocks Up 165% and 209% in 2022 That Could Keep Soaring in 2023

3 Soaring Biotech Stocks That Could Climb Much Higher

BLTE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Belite Bio

BLTE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Belite Bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BLTE

What is the current price of Belite Bio?

What is the 52-week range for Belite Bio?

How much debt does Belite Bio have?

How much cash does Belite Bio have on hand?

What is Belite Bio’s dividend yield?

Premium Investing Services